// App-Quantinova.ai

Su1292 : Biomarker Panel for Prediction of Mucosal Healing in Patients With Crohn's Disease Under Infliximab Therapy

Researchers

Presenter

  • Talat Bessissow

Principal Investigators

  • Thomas Billiet

  • Gert A. Van Assche

  • Ingrid Arijs

  • Ghislain Opdenakker

  • Severine Vermeire

  • Isabelle Cleynen

  • Richard Kirkland

  • Xinjun Liu

  • Scott Hauenstein

  • Katherine Drake

  • Sharat Singh

  • Marc Ferrante

  • Paul J. Rutgeerts

Medical Centers

  • Rega Institute for Medical Research, Department of Microbiology and Immunology, KULeuven, Leuven, Belgium

Locations

  • Canada

  • Belgium

Companies

  • Prometheus Laborator

  • Translational Resear

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Crohn's disease

Biomarkers

  • C reactive protein

  • Epidermal growth factor

  • Hepatocyte growth factor

  • Interleukin 10

  • Interleukin 6

  • Interleukin-2

  • Interleukin-8

  • Serum amyloid A

  • TNF superfamily member 12

  • Tumor necrosis factor

Drug/Treatment

  • Infliximab

  • Interleukin-10

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved